mdi Consultants
14
Nov
ANDA
FDA Update Not All Drugs Products Are Created Equally – PLEASE REVIEW THIS FDA publishes draft guidance for industry: Sameness Evaluations in an ANDA – Active Ingredients On November 8, 2022, FDA published a new draft guidance for industry entitled “Sameness Evaluations in an ANDA – Active Ingredients.” The guidance is intended to assist applicants